Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 11, Novembre 2013
Page(s) 954 - 956
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20132911008
Publié en ligne 20 novembre 2013
  1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008 ; 454 : 436–444. [CrossRef] [PubMed]
  2. Riordan SM, Williams R. The intestinal flora and bacterial infection in cirrhosis. J Hepatol 2006 ; 45 : 744–757. [CrossRef] [PubMed]
  3. Yu LX, Yan HX, Liu Q, et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 2010 ; 52 : 1322–1333. [CrossRef] [PubMed]
  4. Dapito DH, Mencin A, Gwak GY, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012 ; 21 : 504–516. [CrossRef] [PubMed]
  5. Wang Z, Yan J, Lin H, et al. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice. Hepatology 2013 ; 57 : 1869–1881. [CrossRef] [PubMed]
  6. Zhang HL, Yu LX, Yang W, et al. Profound impact of gut homeostasis on chemically induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol 2012 ; 57 : 803–812. [CrossRef] [PubMed]
  7. McKnite AM, Perez-Munoz ME, Lu L, et al. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One 2012 ; 7 : e39191. [CrossRef] [PubMed]
  8. Friswell MK, Gika H, Stratford IJ, et al. Site and strain-specific variation in gut microbiota profiles, metabolism in experimental mice. PLoS One 2010 ; 5 : e8584. [CrossRef] [PubMed]
  9. Agundez JA, Garcia-Martin E, Devesa MJ, et al. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology 2012 ; 82 : 35–40. [CrossRef] [PubMed]
  10. Liang B, Chen R, Wang T, et al. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma. Clin Cancer Res 2013 ; 19 : 2905–2916. [CrossRef] [PubMed]
  11. Burcelin R, Chabo C, Blasco-Baque V, et al. Le microbiote intestinal à l’origine de nouvelles perspectives thérapeutiques pour les maladies métaboliques ? Med Sci (Paris) 2013 ; 29 : 800–806. [CrossRef] [EDP Sciences] [PubMed]
  12. Hoarau G, Colombel JF, Poulain D, Sendid B. Implication de la flore fongique intestinale dans le développement de la maladie de Crohn. Med Sci (Paris) 2013 ; 29 : 691–693. [CrossRef] [EDP Sciences] [PubMed]
  13. Imler JL, Ferrandon D. Le printemps de l’immunité innée couronné à Stockholm. Med Sci (Paris) 2011 ; 27 : 1019–1024. [CrossRef] [EDP Sciences] [PubMed]
  14. Jamilloux Y, Henry T. Les inflammasomes : plates-formes de l’immunité innée. Med Sci (Paris) 2013 ; 29 : 975–984. [CrossRef] [EDP Sciences] [PubMed]